STORY BYIf you regularly take medication for some arthritis pain, you may be wondering if the treatment is worse than the disease. Concerns that some popular drugs widely prescribed for arthritis and inflammation may put patients at greater risk for serious cardiovascular events have recently had their 15 minutes of infamy. Here's why.
The drugs most in question are a type of non-steroidal anti-inflammatory drug (NSAID) that stops production of one type of cyclooxygenase (COX), an enzyme involved in making prostaglandins. Among other things, prostaglandins play a role in the painful, inflammatory response to injury. Some prostaglandins also are thought to "turn on" pain receptors.
General NSAIDs, like the familiar Advil or Motrin (ibuprofen), block production of both types of cyclooxygenase, COX-1 and COX-2.
COX-1 is involved in activities such as platelet activation, gastrointestinal processes and kidney function. COX-2 is produced mainly as a response to tissue damage and injury.
Drugs such as Vioxx, Celebrex and Bextra that have caused the most recent concern are called COX-2 inhibitors because they block production of COX-2 without affecting COX-1. This was a good thing at first-these drugs appeared to stop pain and inflammation without upsetting your stomach, causing bleeding or damaging kidneys.
COX-2 inhibitors are now associated with higher risks of blood clots, strokes and heart attacks than their older cousins, the general NSAIDS (ibuprofen, naproxen and aspirin). These cardiovascular accidents may be related to the drug's failure to block platelet activation, a heart-protective effect of COX-1 drugs. The COX-2 drugs, however, are thought to offer greater protection against gastrointestinal side effects of long-term NSAID therapy, such as stomach bleeding and ulcers.
"We clearly need more data," says John D. Reveille, MD, professor and director of the Division of Rheumatology at The University of Texas Medical School at Houston. "It is premature for every patient to stop using these medications; but patients with established heart disease, high cholesterol or diabetes or those with kidney disease should be a lot more cautious." COX-2 drugs are much more expensive than other NSAIDS, Reveille points out, "and there is no indication that they are any more effective. And now we know about the possible vascular problems."
Prior Vioxx or other COX-2 patients should not have lingering negative effects after stopping therapy, Reveille says. If you had no symptoms while you were taking the drug, it is unlikely that future symptoms will appear. However, the COX-2 inhibitors should be taken only if you cannot tolerate possible gastrointestinal side effects of other NSAIDs. Most patients should be able to use other types of NSAIDs.
Reveille also warns that even over-the-counter NSAIDs should be taken only as directed on product labeling, for short-term use.
"Anybody taking NSAIDs long term, especially at doses exceeding what the over-the-counter NSAIDs have recommended, should be followed by his or her physician and have blood tests once or twice a year to check for kidney or liver problems," he warns. "The frequency of side effects is also dose-related, so those taking higher doses (such as ibuprofen 800 mg four times a day or naproxen 500 mg twice a day) should be monitored."
Reveille says that if you are taking the drugs only to relieve periodic pain, such as muscle ache or headache, acetaminophen (Tylenol) could suffice.
However, any medication, even over-the-counter products, can be associated with problems if taken over a long period and at a high dosage. Recently the National Institutes of Health halted a study after three years when researchers found that patients taking a general NSAID, a well-known over-the-counter medication (naproxen), had a 50 percent greater incidence of cardiovascular events, heart attack or stroke after three years of use than patients in the study not taking the drug.
Acetaminophen also can be dangerous to the liver if dosage recommendations aren't followed.
There are over 100 types of arthritis. In some, such as gout or rheumatoid arthritis, NSAID use is probably necessary. But in the most common type, osteoarthritis, which affects up to 40 percent of the population, alternatives to NSAIDs exist:
As is often the case, the risks versus the potential benefits of any drug should be considered before planning long-term treatment with them. Meanwhile, further studies that test the true safety of NSAIDs, especially selective COX-2 inhibitors, should be carried out.
Dr. John D. Reveille is a professor in and director of the Division of Rheumatology at UT Medical School.
See Dr. Reveille also at:
What a Difference
60 Minutes Can Make
It’s just an hour. At 2 a.m. on March 14, time changes as we “spring forward” one hour overnight. It wouldn’t seem to be that big of a deal, but it is according to researchers at the University of Michigan’s Center for Sleep Science. They have found that in the days immediately following the spring time change each year more people have serious car accidents, most likely due to the sleep loss and adjustments that our biological clocks must make to the new schedule.
To prepare for the time change, start going to bed and waking up 15 minutes earlier each day between now and the start of Daylight Savings Time. This helps reset your biological clock.
The spring time change isn’t the only time we should be concerned about our levels of sleep. According to the sleep researchers, adults ought to get 8 to 8.5 hours of sleep every night, but few of us do. This does more than leave us groggy in the mornings. Findings have shown that a lack of sleep may increase risks of obesity, diabetes, stroke and heart attacks.
The National Sleep Foundation offers this advice for healthy sleep: